Popular cold and cough treatment may create respiratory distress in young childrenJanuary 13, 2009WINSTON-SALEM, N.C. - New research out of Wake Forest University Baptist Medical Center suggests that Vicks® VapoRub®, the popular menthol compound used to relieve symptoms of cough and congestion, may instead create respiratory distress in infants and small children. The study appears in this month's issue of Chest, the peer-reviewed journal of the American College of Chest Physicians, and reports that the product may stimulate mucus production and airway inflammation, which can have severe effects on breathing infants or young children because of the small size of their airways. "The ingredients in Vicks can be irritants, causing the body to produce more mucus to protect the airway," said Bruce K. Rubin, M.D., lead author of the study and a professor in the department of pediatrics at Brenner Children's Hospital, part of Wake Forest Baptist. "Infants and young children have airways that are much narrower than those of adults, so any increase in mucus or inflammation can narrow them more severely." Vicks® VapoRub® was first compounded in 1891, in Greensboro. It was introduced in 1905 with the name Vick's Magic Croup Salve. The flu epidemic of 1918 increased sales from $900,000 to $2.9 million in just one year and Procter & Gamble has since marketed the product as "The only thing more powerful than a mother's touch." The salve is widely used to relieve symptoms of colds and congestion, but there are few data supporting an actual clinical benefit, according to Rubin. Vicks has been reported to cause inflammation in the eyes, mental status changes, lung inflammation, liver damage, constriction of airways and allergic reactions. Interest in conducting the study developed after Rubin and colleagues treated an infant who was taken to the emergency room after developing severe respiratory distress following the application of Vicks directly under her nose. Researchers sought to determine the effect of the product on the respiratory system using ferrets, which have an airway anatomy and cellular composition similar to humans. The team conducted tests on healthy ferrets and ferrets that had tracheal inflammation (simulating a person with a chest infection) that measured the effects of Vicks on mucus secretion and buildup in the airways, and fluid buildup in the lungs. Results showed that Vicks exposure increased mucus secretion in both normal and inflamed airways. In addition, the studies showed that exposure to the product decreased the rate by which mucus was cleared from the trachea. The findings support current product labeling, which indicates the product should not be used on children under 2 years of age. However, many parents continue to use Vicks on their sick children, often rubbing the salve on the feet or chest, Rubin said. "I recommend never putting Vicks in, or under, the nose of anybody-adult or child," Rubin said. "I also would follow the directions and never use it at all on children under age 2." Even when directions are followed, Vicks will make people with congestion more comfortable, but it does nothing to increase airflow or actually relieve congestion, Rubin added. "Some of the ingredients in Vicks, notably the menthol, trick the brain into thinking that it is easier to breathe by triggering a cold sensation, which is processed as indicating more airflow," he said. "Vicks may make you feel better but it can't help you breathe better." In addition to Vicks® VapoRub®, decongestants are not recommended for young children. "Mucus is one of the most effective ways that our body protects our air passages like the nose and bronchial tubes," Rubin said. "However, lots of mucus and inflammation can cause congestion, especially in little noses. Cough and cold medicines and decongestants are dangerous and neither effective nor safe for young children. Medications to dry up nasal passages also have problems," Rubin said. "The best treatments for congestion are a bit of saline (salt water) and gentle rubber bulb suction, warm drinks or chicken soup, and, often, just letting the passage of time heal the child." Dr. Rubin also notes that if a child is struggling to breathe, it is a medical emergency and would require the child to be seen by a doctor as quickly as possible. Wake Forest University Baptist Medical Center |
|||||||||||||||||||||
| Related Respiratory Distress Current Events and Respiratory Distress News Articles Barn Personnel Experience Higher-Than Average Rates of Respiratory Symptoms The estimated 4.6 million Americans involved in the equine industry may be at risk of developing respiratory symptoms due to poor air quality in horse barns. Mechanical ventilation for patients with lung damage don't always work as planned As more Canadians are diagnosed with H1N1 influenza infection, some will be admitted to hospital. The most severely affected may be treated in the intensive care unit (ICU) and placed on a mechanical ventilator to help them breathe while they recover from the infection. USU scientists report major advance in human antibody therapy against deadly Nipah virus A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus. Interactions with aerosols boost warming potential of some gases For decades, climate scientists have worked to identify and measure key substances -- notably greenhouse gases and aerosol particles -- that affect Earth's climate. Critical illness from 2009 H1N1 in Mexico associated with high fatality rate Critical illness from 2009 influenza A(H1N1) in Mexico occurred among young patients, was associated with severe acute respiratory distress syndrome and shock, and had a fatality rate of about 40 percent. Most H1N1 patients with respiratory failure treated with oxygenating system survive illness Despite the severity of disease and the intensity of treatment, most patients in Australia and New Zealand who experienced respiratory failure as a result of 2009 influenza A(H1N1) and were treated with a system that adds oxygen to the patient's blood survived the disease. Intensive care procedure saves lives: Swine flu study A research team has warned medical experts in the Northern Hemisphere not to underestimate the serious impact of the H1N1 (Swine flu) virus with a new report showing that many patients who were critically ill with the virus required prolonged life support treatment with heart-lung machines. LSUHSC researcher identifies new target to prevent fatal flu lung complication Research led by Dr. Jay Kolls, Professor and Chairman of Genetics at LSU Health Sciences Center New Orleans, has identified a therapeutic target for acute lung injury resulting in acute respiratory distress syndrome, a highly fatal complication of influenza infection. Nanoparticle-based battlefield pain treatment moves step closer University of Michigan scientists have developed a combination drug that promises a safer, more precise way for medics and fellow soldiers in battle situations to give a fallen soldier both morphine and a drug that limits morphine's dangerous side effects. The first gene-encoded amphibian toxin isolated Researchers in China have discovered the first protein-based toxin in an amphibian -a 60 amino acid neurotoxin found in the skin of a Chinese tree frog. This finding may help shed more light into both the evolution of amphibians and the evolution of poison. More Respiratory Distress Current Events and Respiratory Distress News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||